Riverhead Capital Management’s Celgene Corp CELG Stock Holding History

Riverhead Capital Management’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$745K	Buy	7,500 +4,458	+147%	+$424K	0.03%	572
2019 Q2	$281K	Sell	3,042 -13,291	-81%	-$1.26M	0.01%	991
2019 Q1	$1.54M	Sell	16,333 -17,269	-51%	-$1.51M	0.06%	374
2018 Q4	$2.15M	Buy	33,602 +9,261	+38%	+$684K	0.1%	270
2018 Q3	$2.18M	Sell	24,341 -2,436	-9%	-$215K	0.08%	306
2018 Q2	$2.13M	Buy	26,777 +6,192	+30%	+$514K	0.08%	301
2018 Q1	$1.84M	Buy	20,585 +1,922	+10%	+$185K	0.08%	298
2017 Q4	$1.95M	Buy	18,663 +225	+1%	+$25.4K	0.08%	280
2017 Q3	$2.69M	Sell	18,438 -2,040	-10%	-$278K	0.13%	212
2017 Q2	$2.66M	Buy	20,478 +1,212	+6%	+$149K	0.13%	201
2017 Q1	$2.4M	Buy	19,266 +1,318	+7%	+$158K	0.13%	224
2016 Q4	$2.08M	Sell	17,948 -1,700	-9%	-$189K	0.13%	214
2016 Q3	$2.05M	Buy	19,648 +17,272	+727%	+$1.87M	0.13%	204
2016 Q2	$51K	Sell	2,376 -191,156	-99%	-$19.8M	﹤0.01%	1322
2016 Q1	$19.4M	Sell	193,532 -31,403	-14%	-$3.23M	0.27%	100
2015 Q4	$26.9M	Sell	224,935 -6,688	-3%	-$774K	0.39%	60
2015 Q3	$25.1M	Sell	231,623 -3,656	-2%	-$454K	0.4%	67
2015 Q2	$27.2M	Buy	235,279 +10,210	+5%	+$1.17M	0.41%	62
2015 Q1	$25.9M	Sell	225,069 -1,988	-0.9%	-$238K	0.39%	71
2014 Q4	$25.4M	Buy	227,057 +3,148	+1%	+$332K	0.39%	71
2014 Q3	$21.2M	Sell	223,909 -4,737	-2%	-$427K	0.37%	71
2014 Q2	$19.6M	Buy	228,646 +28,094	+14%	+$2.14M	0.37%	73
2014 Q1	$14M	Buy	200,552 +15,152	+8%	+$1.2M	0.31%	91
2013 Q4	$15.7M	Sell	185,400 -109,034	-37%	-$8.63M	0.42%	68
2013 Q3	$22.7M	Sell	294,434 -56,000	-16%	-$3.92M	0.74%	32
2013 Q2	$20.5M	Buy	+350,434	New	+$21.1M	0.68%	35

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Riverhead Capital Management's CELG Position: Q3 2019 in Review

Riverhead Capital Management increased its Celgene Corp (CELG) stake by 147% in Q3 2019, buying an estimated $424K and bringing the position to 7,500 shares worth $745K. The position accounts for 0.03% of the portfolio, ranked #572.

Riverhead Capital Management first reported a position in CELG in Q2 2013 and has held it in 26 quarters since. The position peaked at $27.2M in Q2 2015. 1,245 funds tracked by Wall St. Rank hold CELG as of Q3 2019.

Riverhead Capital Management held 7,500 shares of Celgene Corp worth $745K as of Q3 2019.
Riverhead Capital Management bought 4,458 Celgene Corp shares in Q3 2019, an estimated $424K.
Celgene Corp made up 0.03% of Riverhead Capital Management's portfolio in Q3 2019, its #572 holding.
Riverhead Capital Management first reported a position in Celgene Corp in Q2 2013 and has held it in 26 quarters since.
Riverhead Capital Management's Celgene Corp position peaked at $27.2M in Q2 2015.
1,245 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2019.

Based on Riverhead Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.